Form 4: AIM ImmunoTech Director Acquires Shares in Lieu of Cash Compensation

David I. Chemerow, a director of AIM ImmunoTech Inc., acquired 44,899 shares of common stock in lieu of cash compensation on March 14, 2025.

Summary

• On March 14, 2025, David I. Chemerow, a director of AIM ImmunoTech Inc., acquired 44,899 shares of common stock.
• The shares were acquired at a price of $0.116 per share.
• This acquisition was made in lieu of director compensation, as part of the issuer's Cash Conservation Plan.
• Following the transaction, Chemerow's direct ownership of common stock increased to 64,189 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director taking shares instead of cash shows confidence, but it also indicates the company is trying to conserve cash.

Positives

• The acquisition of shares by a director demonstrates confidence in the company.
• The Cash Conservation Plan helps the company manage its cash flow.

Management Comments

• The shares acquired on the Transaction Date were issued in lieu of director compensation pursuant to the issuer's Cash Conservation Plan.

Industry Context

Directors receiving stock in lieu of cash compensation is a strategy sometimes used by companies, particularly smaller ones, to conserve cash. This can be seen as a positive signal if the director believes in the long-term prospects of the company.

Stakeholder Impact

• Shareholders may view the director's share acquisition positively.
• Employees may be concerned about the company's cash conservation efforts.

Key Dates